Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Myocarditis IV: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 1, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Zhaoli Tang1, Zhao Chen2, Beisha Tang3,4,5
1Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya road, Changsha, 410008, Hunan, China. zhaoli.tang@outlook.com.
Primary erythromelalgia (PE) is a rare genetic disorder causing severe extremity pain. Mutations in the SCN9A gene affecting Nav1.7 channels are the primary cause, leading to a need for targeted therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: